Yalınay Dikmen, P. Et Al. 2023. Real-life Experiences with Galcanezumab disclosed New Predictors for Response. 21st International Headache Congress , (Seoul, South Korea), 244-245.

Yalınay Dikmen, P., Baykan, B., Uludüz, D., Özge, A., & Aydınlar, E., (2023). Real-life Experiences with Galcanezumab disclosed New Predictors for Response . 21st International Headache Congress (pp.244-245). Seoul, South Korea

Yalınay Dikmen, PİNAR Et Al. "Real-life Experiences with Galcanezumab disclosed New Predictors for Response," 21st International Headache Congress, Seoul, South Korea, 2023

Yalınay Dikmen, PİNAR Y. Et Al. "Real-life Experiences with Galcanezumab disclosed New Predictors for Response." 21st International Headache Congress , Seoul, South Korea, pp.244-245, 2023

Yalınay Dikmen, P. Et Al. (2023) . "Real-life Experiences with Galcanezumab disclosed New Predictors for Response." 21st International Headache Congress , Seoul, South Korea, pp.244-245.

@conferencepaper{conferencepaper, author={PİNAR YALİNAY DİKMEN Et Al. }, title={Real-life Experiences with Galcanezumab disclosed New Predictors for Response}, congress name={21st International Headache Congress}, city={Seoul}, country={South Korea}, year={2023}, pages={244-245} }